Francesca Berardo

Dr. Francesca Berardo

Pubblications: PubMed

Operative Unit: Glaucoma Operating Unit

Sub-specialties: Refractive Errors of the eye, Glaucoma, Hypovision and visual rehabilitation

Clinical activity: Works at the G.B. Bietti since 2010. Her main activity concerns the ophthalmic assistance in the field of instrumental diagnostics of glaucomatous pathology in clinical and research activity.


Education

Graduated with honors in orthoptics and ophthalmological assistance (2008) at the Cattolica University, Rome.
In 2009 she attended a specialization course in "Visual Rehabilitation" at the University of Florence, Faculty of Medicine and Surgery - Department of Oto-Neuro-Ophthalmological Surgery Sciences.

Roles

  • 2016 to date Permanent Contract as Orthoptist and assistant in ophthalmology at IRCCS G.B. Betti
  • 2013/2015 Fixed term- Contract as Orthoptist and assistant in ophthalmology at IRCCS G.B. Bietti Research Unit Glaucoma
  • 2010/2012 Fellow as orthoptist and assistant in ophthalmology at IRCCS G.B. Bietti Research Unit Glaucoma

Technical support activities for scientific research of the Glaucoma Unit

  • A prospective, double-masked, randomized, multicenter, active- controlled, parallel-group, 6-month study assessing the safety and ocular hypotensive efficacy of PG324 Ophthalmic Solution compared to GANFORT® (bimatoprost 0.03%/timolol 0.5%) Ophthalmic Solution in subjects with elevated intraocular pressure (MERCURY 3)
  • Preservative-free fixed-dose combination of tafluprost 0.0015% / timolol 0.5% in patients with open-angle glaucoma or ocular hypertension: Clinical effectiveness, tolerability and safety in a real world setting
  • Efficacia di una soluzione oftalmica a base di taurina e acido ialuronico in pazienti glaucomatosi e ipertesi oculari in terapia cronica con farmaci ipotonizzanti oculari
  • Safety and Efficacy with Twice Daily Brinzolamide 1% / Brimonidine 0.2% (SIMBRINZA) as an Adjunctive Therapy to Travoprost 0.004% / Timolol 0.5% (DUOTRAV)
  • Intraocular pressure and tolerability Study of Preserved Bimatoprost 0.1% (BMD) or Tafluprost Unit Dose Preservative Free 15microgram/ml  (TUDPF) (Saflutan), in patients with Ocular hypertension or glaucoma suitable for prostaglandin therapy: A Randomized, single masked, 3 month cross-over, Investigator led, European multicentre Trial, II (SPORT II)
  • Clinical performance of Compass in the diagnosis of Glaucoma
  • A phase IV study on the changes in ocular signs and sympotms in patients with ocular hypertension or open angle glaucoma swiched from Ganfort eye drops to Taptiquom eye drops (SANTEN II)
  • Valutazione dei livelli di BDNF ed NGF nel plasma e nelle lacrime di pazienti affetti da glaucoma.NTs e glaucoma.
  • Effetti collaterali dei conservanti: valutazione clinica, citologica e strumentale della superficie oculare
  • Intraocular pressure and tolerability Study of Preservative Free Bimatoprost 0.03% Unit Dose (BUDPF) or preservative free Latanoprost 0.005% Unit Dose (LUDPF) (Monoprost®) in patients with Ocular hypertension or glaucoma: A Randomized, single masked, 3 month cross-over, Investigator led, European multicentre Trial (SPORT)
  • Confronto tra l'effetto dell'associazione fissa bimatoprost-timololo nel ridurre la pressione intraoculare verso le associazioni fisse di inibitori dell'anidrasi carbonica-timololo in pazienti con glaucoma o ipertensione oculare non controllati dalla monoterapia: studio retrospettivo
  • Efficacia di una solizione oftalmica a base di cianocobalamina, taurina e acido ialuronico in pazienti in terapia con farmaci ipotonizzanti oculari
  • Valutare l'efficacia nel ridurre la pressione intraoculare del Miotrab somministrato tre volte al giorno
  • Lumigan 0,1 ®nella attività ambulatoriale quotidiana: studio retrospettivo
  • Effetto apprendimento della perimetria HEP (Heidelberg Edge Perimeter) in pazienti con ipertensione oculare
  • Influenza della dilatazione pupillare nelle misurazioni dello strato delle fibre nervose retiniche (RNFL), della testa del nervo ottico (ONH) e del complesso ganglio cellulare (GCC) con Tomografia a Coerenza Ottica (OCT) Spectral Domain (RTVue -100)
  • Studio longitudinale prospettico per la valutazione dello sviluppo di malattie sulla superficie oculare. Confronto fra pazienti Treatment-Naive (non aventi ricevuto trattamenti specifici) con ipertensione oculare o con glaucoma rispetto a pazienti senza elevata pressione oculare.(SAHARA)
  • Valutazione dell’equivalenza terapeutica di Travoprost PR e Travatan , studio clinico randomizzato in doppio cieco in pazienti affetti da glaucoma o ipertensione oculare.
  • Studio di 2 anni, multicentrico, in doppio cieco, randomizzato, in parallelo sulla sicurezza di LUMIGAN® 0,1 mg/ml rispetto a LUMIGAN® 0,3 mg/ml in pazienti affetti da glaucoma o da ipertensione oculare.
  • A phase III, randomized, double-masked 6-month clinical study to compare the efficacy
  • and safety of the preservative-free fixed-dose combination of tafluprost 0.0015% and timolol
  • 0.5% eye drops to those of tafluprost 0.0015% and timolol 0.5% eye drops given as individual monotherapies in patients with open angle glaucoma or ocular hypertension
  • Confronto tra gli effetti del Bimatoprost 0.01% e Timololo 0.5%  sulla pressione intraoculare circadiana.
  • Multi-Center Study Assessing Efficacy and Tollerability of TRAVATAN solution without BAK, containing Polyquad Preservative (0.004% travoprost) in Patients Previously on latanoprost 0.005% or bimatoprost 0.01% ophthalmic solution Monoterapy.
  • Valutazione dei pazienti con alterazione dello strato delle fibre nervose retiniche con perimetria SITA Standard e perimetria SITA SWAP.
  • A comparison between the Moorfields MDT and established perimeters to discriminate between normal and glaucomatous eyes.